CJC-1295 (Mod GRF 1-29) & Hexarelin Blend (10mg): A Dual‑Pathway Research Tool for Growth Hormone Studies

If your research explores the hypothalamic-pituitary-somatotropic axis, the dynamics of growth hormone (GH) secretion, or the downstream effects of insulin-like growth factor 1 (IGF-1), the CJC-1295 (Mod GRF 1-29) & Hexarelin Blend (10mg) offers a precisely defined, dual‑pathway experimental platform. This 10 mg formulation combines two well‑characterised GH secretagogues—CJC-1295 (Mod GRF 1-29), a modified analog of growth hormone-releasing hormone (GHRH), and Hexarelin, a potent ghrelin receptor agonist. By targeting two distinct receptors that converge at the pituitary level, this blend allows researchers to model the synergistic interplay between the GHRH and ghrelin systems, providing deeper insight into the regulatory circuits that govern GH pulsatility.

At Wuhan Top Miracle Peptides, we supply high‑purity CJC-1295 (Mod GRF 1-29) & Hexarelin Blend (10mg) to research institutions and wholesale buyers across the United Kingdom, France, Germany, Spain, Sweden, Italy, and the USA. Every batch is lyophilised, HPLC‑verified to ≥98% purity, and accompanied by a Certificate of Analysis (COA), ensuring your investigations into GH regulation, IGF‑1 signalling, and metabolic research begin with uncompromising quality.

What Is the CJC-1295 (Mod GRF 1-29) & Hexarelin Blend and How Does It Work?

To fully appreciate the research potential of the CJC-1295 (Mod GRF 1-29) & Hexarelin Blend (10mg), it is essential to understand the distinct yet complementary mechanisms of its two components.

CJC-1295 (Mod GRF 1-29): The Stabilised GHRH Analog

CJC-1295 (Mod GRF 1-29), also referred to as CJC-1295 without DAC (Drug Affinity Complex), is a modified analog of growth hormone-releasing hormone (GHRH). It is a 29‑amino‑acid peptide with four amino acid substitutions that enhance its activity and render it resistant to proteolytic degradation. This modification aims to increase its stability and half‑life compared to the natural peptide.

As a GHRH analogue, Mod GRF 1-29 acts on receptors in the anterior pituitary gland to stimulate the release of human growth hormone in a pulsatile manner. Its molecular formula is C₁₅₂H₂₅₂N₄₄O₄₂, with a molecular weight of approximately 3,367.97 g/mol.

Hexarelin: The Potent Ghrelin Receptor Agonist

Hexarelin (Examorelin) is a synthetic hexapeptide belonging to the growth hormone-releasing peptide (GHRP) class. It acts via specific receptors at both the pituitary and hypothalamic levels to stimulate GH release. Its sequence is His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH₂, with a molecular formula of C₄₇H₅₈N₁₂O₆ and a molecular weight of approximately 887.04 g/mol. It has a CAS number of 140703-51-1.

Hexarelin has a longer terminal half‑life than GHRP‑6 (approximately 70 minutes), which is attributed to the replacement of naturally occurring L‑amino acids with the D‑configuration.

Mechanism of Synergy: Dual‑Pathway Activation

The scientific rationale for combining CJC‑1295 (Mod GRF 1-29) and Hexarelin lies in their convergent yet distinct mechanisms:

• CJC‑1295 (Mod GRF 1‑29) provides the primary stimulus to initiate GH synthesis and release by activating the classical GHRH receptor pathway.

• Hexarelin enhances the amplitude of that response by engaging the ghrelin/secretagogue receptor system, acting via specific receptors at both the pituitary and hypothalamic levels.

• Convergent Signalling: Both pathways converge at the pituitary level. Research has established that combining a GHRH analogue with a GHRP produces synergistic GH release that exceeds either agent alone.

This dual‑pathway activation makes the CJC‑1295 and Hexarelin blend a convergent strategy for probing growth hormone‑related signalling, temporal regulation, and downstream molecular coordination.

Key Research Applications for the CJC-1295 (Mod GRF 1-29) & Hexarelin Blend (10mg)

The CJC-1295 (Mod GRF 1-29) & Hexarelin Blend (10mg) is a versatile tool with applications spanning several domains of endocrinological and metabolic research.

1. Growth Hormone Axis & Pituitary Function Studies

This blend provides a powerful model for investigating the hypothalamic‑pituitary‑somatotropic axis. Researchers can use it to study:

• The synergistic effects of GHRH and ghrelin pathway co‑activation on GH synthesis, storage, and pulsatile release.

• The distinct contributions of GHRH‑mediated and ghrelin‑mediated signalling to overall GH secretion.

• The dynamics of GH pulse amplitude and frequency in response to dual‑pathway stimulation.

2. Metabolic & Body Composition Research

By stimulating endogenous GH release through two pathways, this blend provides a model for studying the downstream metabolic effects of GH and IGF‑1 elevation. Research applications include:

• Metabolic Studies: Investigating the impact of GH modulation on energy balance, nutrient utilisation, and cellular metabolism.

• Lipid Metabolism: Exploring the role of GH in lipolysis and fat metabolism.

• Body Composition: Studying how enhanced GH secretion may influence muscle development, recovery, and overall body composition.

3. Tissue Repair & Regenerative Research

Growth hormone is considered to play a role in cellular proliferation and protein synthesis, making this blend relevant for regenerative studies. Research applications include:

• Muscle Development and Recovery: Investigating the potential of CJC‑1295 and Hexarelin to support muscle development and aid in post‑workout recovery.

• Bone and Joint Health: Exploring the potential benefits of this peptide blend on bone and joint health.

• Cellular Differentiation and Proliferation: Studying how enhanced GH levels may encourage these processes in various tissue types.

4. Receptor Pharmacology & Signalling Research

The blend may offer a multifaceted research modality for probing endogenous growth hormone axis mechanics. Researchers can use it to:

• Investigate the complex interplay between the GHRH and ghrelin systems.

• Study the downstream signalling pathways activated by GHRH and ghrelin receptor co‑stimulation.

• Characterise dual‑GPCR signalling and second‑messenger outputs in the context of GH regulation.

Chemical & Physical Specifications for CJC-1295 (Mod GRF 1-29) & Hexarelin Blend (10mg)

Accurate characterisation of the CJC-1295 (Mod GRF 1-29) & Hexarelin Blend (10mg) is essential for reproducible experimental design.

Note: The 10 mg mass represents the total peptide weight of the blend. The exact ratio of CJC‑1295 (Mod GRF 1‑29) to Hexarelin is determined by the formulation (contact for details). CJC‑1295 in this blend does not contain the Drug Affinity Complex (DAC) moiety. The version without DAC creates short, sharp GH spikes that closely mimic natural physiology.

Reconstitution & Handling Protocol for the CJC-1295 (Mod GRF 1-29) & Hexarelin Blend (10mg)

Proper reconstitution of the CJC-1295 (Mod GRF 1-29) & Hexarelin Blend (10mg) is critical for maintaining the structural integrity and biological activity of both peptides.

Step 1 – Preparation

• Bring the sealed blend vial and your chosen diluent (sterile bacteriostatic water or sterile PBS, pH 5‑7) to room temperature. Condensation can degrade the lyophilised powder.

• Clean your work surface with 70% ethanol and lay out sterile syringes, alcohol wipes and a clean work mat.

Step 2 – Vial Sanitisation

• Wipe the rubber stopper of the blend vial with a fresh 70% ethanol wipe. Allow the alcohol to evaporate completely before piercing.

Step 3 – Reconstitution

• Draw your desired volume of diluent into a sterile syringe. A common starting concentration for research applications is 10 mg per 1 mL of diluent, yielding a 10 mg/mL total peptide concentration.

• Insert the needle and slowly inject the diluent against the inner glass wall. Do not spray directly onto the lyophilised powder.

• Gently swirl the vial until the solution is clear and fully dissolved. Do not shake vigorously, as shaking can cause denaturation.

Step 4 – Aliquoting & Storage

• Immediately after dissolution, aliquot the reconstituted peptide blend into single‑use sterile vials.

• Store aliquots at –20°C. Avoid repeated freeze‑thaw cycles.

• Once thawed, store at 2‑8°C and use within a short period.

Concentration Reference Table

Adjust diluent volume based on your experimental requirements. The exact concentration of each individual peptide within the blend is determined by the formulation’s component ratio.

Storage & Stability Guidelines for CJC-1295 (Mod GRF 1-29) & Hexarelin Blend (10mg)

Why Choose Wuhan Top Miracle Peptides for the CJC-1295 (Mod GRF 1-29) & Hexarelin Blend (10mg)?

As an authentic licensed peptide supplier based in the United Kingdom, we supply the CJC-1295 (Mod GRF 1-29) & Hexarelin Blend (10mg) and a wide range of research‑grade compounds under rigorous quality assurance protocols, fully aligned with Google’s E‑E‑A‑T standards (Experience, Expertise, Authoritativeness, Trustworthiness).

• Verified Purity: Independent HPLC analysis with purity guaranteed ≥98% for each component, every batch.

• GMP‑Compliant Manufacturing: All peptides are synthesised under strict quality control conditions.

• Full Traceability: Batch‑specific Certificates of Analysis (COA) are available for every order.

• Wholesale Supply: We serve research institutions, laboratories, and wholesale buyers across the UK, EU, and USA with flexible volume pricing and reliable logistics.

• UK‑Based Regulatory Compliance: All products are supplied strictly as research‑grade chemicals for laboratory use only (RUO).

Researchers across the United Kingdom—including those at leading institutions in London, Cambridge, Oxford, Manchester, and Edinburgh—trust us for fast domestic delivery, transparent documentation and professional technical support.

FAQ: CJC-1295 (Mod GRF 1-29) & Hexarelin Blend (10mg)

What is the CJC-1295 (Mod GRF 1-29) & Hexarelin Blend (10mg)?
It is a research‑grade formulation combining CJC-1295 (Mod GRF 1-29, a modified GHRH analog also known as CJC-1295 without DAC) and Hexarelin (a potent ghrelin receptor agonist). It is used as a dual‑pathway tool to study growth hormone stimulation, IGF‑1 signalling, and metabolic research.

How does each component work?
CJC-1295 (Mod GRF 1-29) binds to GHRH receptors on pituitary somatotrophs, stimulating GH synthesis and release in a pulsatile manner. Hexarelin binds to the growth hormone secretagogue receptor (GHS‑R1a), amplifying the amplitude of GH secretory pulses through its action at both pituitary and hypothalamic levels.

 What is the proposed synergy between CJC-1295 and Hexarelin?
CJC-1295 provides the primary stimulus to initiate GH production, while Hexarelin enhances the amplitude of that response. Research has established that combining a GHRH analogue with a GHRP produces synergistic GH release that exceeds either agent alone.

What purity does your CJC-1295 (Mod GRF 1-29) & Hexarelin Blend (10mg) meet?
Each component is tested to ≥98% purity by HPLC. A Certificate of Analysis (COA) is supplied with every order.

How should I reconstitute this peptide blend?
Reconstitute with sterile bacteriostatic water or sterile PBS (pH 5‑7). Allow the vial to reach room temperature, then slowly inject the diluent against the inner glass wall and swirl gently. Do not shake.

How should I store reconstituted peptide blends?
Reconstituted blends should be stored at 2‑8°C for short‑term use. For longer storage, aliquot immediately into single‑use vials and store at –20°C for up to 3 months. Avoid repeated freeze‑thaw cycles.

 What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 without DAC (Mod GRF 1-29) does not contain a drug affinity complex moiety and has a shorter half‑life than the DAC‑conjugated version. The version without DAC supports a more pulsatile release pattern that closely mimics natural physiology.

Is this peptide blend legal to purchase in the UK for research?
Yes. This blend is a laboratory reagent sold for research use only (RUO). It is not authorised as a medicinal product by the MHRA, EMA, or FDA.

Does Wuhan Top Miracle Peptides ship internationally?
Yes. We ship across the EU (France, Germany, Spain, Sweden, Italy) and to the USA from our UK warehouse. Wholesale pricing is available for bulk orders.

Wholesale CJC-1295 (Mod GRF 1-29) & Hexarelin Blend (10mg) Supply Across the UK and Europe

Wuhan Top Miracle Peptides supports wholesale peptide blend buyers in the United Kingdom and international markets.

We Support Enquiries From:

• United Kingdom
• France
• Germany
• Spain
• Sweden
• Italy
• USA
• Wider Europe

For larger blend enquiries, contact our team before ordering. This helps confirm stock, documentation, shipping options, component identity, blend ratio, and buyer verification requirements.

Where to Source CJC Mod GRF Hexarelin Blend 10mg in the UK

If you are searching for where to source CJC Mod GRF Hexarelin Blend 10mg in the UK, Wuhan Top Miracle Peptides provides a simple professional enquiry process.

Professional Enquiry Process

1. Review the blend product details.
2. Check the current label and batch information.
3. Confirm whether the batch lists CJC-1295, Mod GRF 1-29, or another documented identity.
4. Confirm whether the CJC-related component includes DAC.
5. Confirm whether Hexarelin is listed as a component.
6. Ask about the total vial content and blend ratio.
7. Ask about COA and purity-related documentation.
8. Confirm sequence and salt form for each component where required.
9. Confirm your shipping country.
10. Discuss wholesale quantity requirements.
11. Complete buyer verification where required.
12. Place a professional enquiry with support from our team.

CJC-1295 (Mod GRF 1-29) & Hexarelin Blend (10mg)

Bulk Peptides Page
Shipping & Returns Page
Contact Us Page
Shop Page
Quality / Compliance Page
Hexarelin Product Page
Mod GRF 1-29 Product Page
Scientific or compound reference source
GOV.UK / MHRA
Google Search Central
ASA / CAP Code Section 12

CJC-1295 (Mod GRF 1-29) & Hexarelin Blend (10mg)

From its innovative design as a dual‑pathway GH secretagogue blend to its well‑documented role in modelling the synergistic interplay between the GHRH and ghrelin systems, the CJC-1295 (Mod GRF 1-29) & Hexarelin Blend (10mg) provides a uniquely versatile platform for advanced endocrinological and metabolic research. Its ability to stimulate endogenous GH release through two distinct yet convergent pathways—supported by research demonstrating synergistic GH release and peer‑reviewed studies—makes it a valuable addition to any laboratory investigating the GH/IGF‑1 axis. By choosing high‑purity, lab‑verified CJC-1295 (Mod GRF 1-29) & Hexarelin Blend (10mg) from Wuhan Top Miracle Peptides, you ensure that your research is built on a foundation of quality, reproducibility, and scientific integrity.

Ready to advance your research with the CJC-1295 (Mod GRF 1-29) & Hexarelin Blend (10mg)? Browse our product catalogue, request a wholesale quote, or contact our support team today to discuss your laboratory’s specific needs. Place your order now and receive GMP‑grade research peptides delivered directly to your facility in the UK, EU, or USA.